Clinical trial
Permeability Enhancement to Reduce Chronic Inflammation
NCT01582893 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Permeability Enhancement to Reduce Chronic Inflammation
- Lead sponsor
- Vantive Health LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- July 31, 2013
- Enrollment
- 50 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, inflammation